[Federal Register Volume 83, Number 84 (Tuesday, May 1, 2018)]
[Notices]
[Page 19065]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09097]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public, limited only by room 
seating. The meeting room accommodates approximately 400 people. Time 
will be available for public comment. The public is welcome to submit 
written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt is June 11, 2018. Written comments must include 
full name, address, organizational affiliation, email address of the 
speaker, topic being addressed and specific comments. Written comments 
must not exceed one single-spaced typed page with 1-inch margins 
containing all items above. Only those written comments received 10 
business days in advance of the meeting will be included in the 
official record of the meeting. Public comments made in attendance must 
be no longer than 3 minutes and the person giving comments must attend 
the public comment session at the start time listed on the agenda. Time 
for public comments may start before the time indicated on the agenda. 
The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP 
website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on June 20, 2018, 8:00 a.m. to 5:30 
p.m., EDT, and June 21, 2018, 8:30 a.m. to 12:30 p.m. EDT.

ADDRESSES: CDC, 1600 Clifton Road NE, Tom Harkin Global Communications 
Center, Kent `Oz' Nelson Auditorium, Atlanta, GA 30329-4027.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, CDC, NCIRD, telephone 404-639-8836, email 
[email protected].

SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with 
advising the Director, CDC, on the use of immunizing agents. In 
addition, under 42 U.S.C. 1396s, the committee is mandated to establish 
and periodically review and, as appropriate, revise the list of 
vaccines for administration to vaccine-eligible children through the 
Vaccines for Children (VFC) program, along with schedules regarding 
dosing interval, dosage, and contraindications to administration of 
vaccines. Further, under provisions of the Affordable Care Act, section 
2713 of the Public Health Service Act, immunization recommendations of 
the ACIP that have been approved by the Director of the Centers for 
Disease Control and Prevention and appear on CDC immunization schedules 
must be covered by applicable health plans.
    Matters to be Considered: The agenda will include discussions on 
Influenza vaccines, anthrax vaccine, Japanese encephalitis vaccines, 
human papillomavirus vaccines, pneumococcal vaccines, zoster vaccines, 
pertussis vaccines, and mumps. A recommendation vote is scheduled for 
Influenza vaccines, anthrax vaccine. A tentative vote is scheduled 
human papillomavirus vaccines. Agenda items are subject to change as 
priorities dictate. For updated information on the meeting agenda visit 
https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2018-09097 Filed 4-30-18; 8:45 am]
BILLING CODE 4163-18-P